Skip to content

PeriPharm Inc.

Request correction

Canadian consultancy specializing in pharmacoeconomics and health evaluative research, supporting market access for innovative therapies.

Last updated September 27, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

PeriPharm Inc. is a Canadian company founded in 2003 and based in Montreal, Quebec. It specializes in pharmacoeconomics and health evaluative research, with a mission to provide high-quality, diversified services that ensure optimal market access for its clients. The firm works closely with clients to meet the needs of the pharmaceutical and health technology industry, leveraging deep knowledge of the Canadian healthcare system and payer requirements. PeriPharm's core services include payer submissions (for INESSS, CDR, and private payers), economic evaluations in health (economic model development, budget impact analyses, cost-of-disease studies, and negotiation tools), real-world evidence research (patient-reported outcomes, administrative database analyses, and key opinion leader interviews), evidence synthesis (systematic literature reviews, network meta-analyses, and indirect comparisons), strategic consulting (licensing opportunity assessment, market access strategic plans, and critical review of payer submissions), and health economics training (introductory pharmacoeconomics and customized training). The company distinguishes itself through its rigorous academic approach, recognized expertise in pharmacoeconomics and evaluative research spanning over 20 years, and a commitment to flexibility and client service. PeriPharm has contributed to the success of numerous market access initiatives in Canada. It operates as a private company and is not publicly listed.

History

PeriPharm Inc. was founded in 2003 as a Canadian company specializing in pharmacoeconomics and health evaluative research. Based in Montreal, Quebec, the firm has built its reputation on providing high-quality services to support market access for innovative health technologies. Over more than two decades, PeriPharm has developed deep expertise in the Canadian healthcare system and payer requirements, contributing to numerous successful market access initiatives. The company's rigorous academic approach and flexible service offerings have positioned it as a leader in its field. As of its official website, PeriPharm continues to operate as a private consultancy serving the pharmaceutical and health technology industries.

  • 2003

    PeriPharm Inc. founded in Canada.

Products and positioning

Academic rigor and deep knowledge of the Canadian healthcare system to facilitate market access for innovative therapies.

  • Payer submissions

    Preparation of reimbursement requests for INESSS, CDR and private payers.

  • Economic evaluations in health

    Development and adaptation of economic models, budget impact analyses, cost-of-disease studies, and negotiation tools.

  • Real-world evidence research

    Patient-reported outcomes, administrative database analyses, and key opinion leader interviews.

  • Evidence synthesis

    Systematic literature reviews, network meta-analyses, and indirect comparisons.

  • Strategic consulting

    Licensing opportunity assessment, market access strategic plans, and critical review of payer submissions.

  • Health economics training

    Introductory pharmacoeconomics and customized training.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/peripharm-inc-canada · Editorial policy · How profiles are compiled